FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Mylan Pharmaceuticals Mycophenolate Mofetil for Injection Recall

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per car…

MYLAN PHARMACEUTICALS INC · Morgantown, WV

Risk level
Class II
Reported by FDA
Aug 5, 2026
Recall ID
D-0734-2026
Check your lot numberHow we source this data

Summary

Mylan Pharmaceuticals recalled Mycophenolate Mofetil for Injection starting Jul 2, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0734-2026 on Aug 5, 2026. Reason: Presence of precipitate. Status: Ongoing.

Why it was recalled

Presence of precipitate

Product description

Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).

Lot numbers, UPCs & expiration codes

Lot #: 3241653, Exp 4/30/2027

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0734-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 2, 2026
FDA report date
Aug 5, 2026
Quantity
5688 vials
Recall type
Voluntary: Firm initiated
Recalling firm
MYLAN PHARMACEUTICALS INC

Original FDA data

Every field from FDA enforcement report D-0734-2026, exactly as published.

Show all FDA fields
City
Morgantown
State
WV
Status
Ongoing
Country
United States
Event ID
99364
Address
1311 Pineview Dr
Code information
Lot #: 3241653, Exp 4/30/2027
Postal code
26505-3276
Report date
Aug 5, 2026
Product type
Drugs
Recall number
D-0734-2026
Classification
Class II
Recalling firm
MYLAN PHARMACEUTICALS INC
Product quantity
5688 vials
Reason for recall
Presence of precipitate
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
Distribution pattern
USA Nationwide
Recall initiation date
Jul 2, 2026
Initial firm notification
Letter
Center classification date
Aug 4, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0734-2026, published Aug 5, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls